M. Issa

401 total citations
11 papers, 312 citations indexed

About

M. Issa is a scholar working on Rheumatology, Genetics and Surgery. According to data from OpenAlex, M. Issa has authored 11 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 3 papers in Genetics and 2 papers in Surgery. Recurrent topics in M. Issa's work include Rheumatoid Arthritis Research and Therapies (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Systemic Lupus Erythematosus Research (3 papers). M. Issa is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Systemic Lupus Erythematosus Research (3 papers). M. Issa collaborates with scholars based in United States, Japan and Canada. M. Issa's co-authors include Hertzel C. Gerstein, J.‐F. Yale, E. Dempsey, John A. Stewart, Stewart B. Harris, Melinda Gooderham, Eric L. Simpson, Fabio P. Nunes, Diamant Thaçi and Kristian Reich and has published in prestigious journals such as Annals of the Rheumatic Diseases, Diabetic Medicine and Journal of the European Academy of Dermatology and Venereology.

In The Last Decade

M. Issa

10 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Issa United States 5 150 97 70 67 39 11 312
Luciano Ibba Italy 10 10 0.1× 174 1.8× 47 0.7× 63 0.9× 29 0.7× 36 264
P. Modiano France 9 7 0.0× 64 0.7× 111 1.6× 8 0.1× 29 0.7× 35 272
Domenico Rosace Spain 8 7 0.0× 36 0.4× 12 0.2× 111 1.7× 63 1.6× 9 262
Mariafrancesca Catalano Italy 6 52 0.3× 8 0.1× 5 0.1× 20 0.3× 72 1.8× 7 397
Megan N. Landis United States 7 4 0.0× 159 1.6× 37 0.5× 64 1.0× 19 0.5× 11 239
Ricardo Madrigal‐Burgaleta Spain 14 4 0.0× 184 1.9× 129 1.8× 139 2.1× 29 0.7× 29 645
Karl M. Hoegler United States 6 9 0.1× 103 1.1× 27 0.4× 3 0.0× 32 0.8× 15 244
Hye Yoon Jang South Korea 6 12 0.1× 34 0.4× 11 0.2× 28 0.4× 8 0.2× 10 105
William C. Ports United States 11 4 0.0× 386 4.0× 142 2.0× 247 3.7× 25 0.6× 21 534
Teppei Hagino Japan 14 13 0.1× 354 3.6× 156 2.2× 191 2.9× 20 0.5× 51 439

Countries citing papers authored by M. Issa

Since Specialization
Citations

This map shows the geographic impact of M. Issa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Issa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Issa more than expected).

Fields of papers citing papers by M. Issa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Issa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Issa. The network helps show where M. Issa may publish in the future.

Co-authorship network of co-authors of M. Issa

This figure shows the co-authorship network connecting the top 25 collaborators of M. Issa. A scholar is included among the top collaborators of M. Issa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Issa. M. Issa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Bieber, Thomas, Jacob P. Thyssen, Kristian Reich, et al.. (2020). Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials. Journal of the European Academy of Dermatology and Venereology. 35(2). 476–485. 110 indexed citations
3.
Weinblatt, M., et al.. (2018). Cardiovascular safety - Update from up to 6 years of treatment with baricitinib in rheumatoid arthritis clinical trials. Oxford University Research Archive (ORA) (University of Oxford). 2 indexed citations
4.
Kremer, Joel M., et al.. (2017). FRI0090 Analysis of neutrophils, lymphocytes, and platelets in pooled phase 2 and phase 3 studies of baricitinib for rheumatoid arthritis. Annals of the Rheumatic Diseases. 76. 512–512. 17 indexed citations
5.
Takeuchi, Tsutomu, R. Fleischmann, Michael Schiff, et al.. (2017). AB0281 Characterization of changes in lymphocyte subsets in baricitinib-treated patients with early, dmard naÏve, rheumatoid arthritis in a phase 3 study. Annals of the Rheumatic Diseases. 76. 1147–1147. 1 indexed citations
6.
Takeuchi, Tsutomu, Mark C. Genovese, Lechun Xie, et al.. (2016). OP0228 Baricitinib Dose Step-Down Following Disease Control in Patients with Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 75. 144–144. 7 indexed citations
7.
Tanaka, Yoshiya, R. Fleischmann, M. Schiff, et al.. (2016). THU0209 Characterization of Changes in Lymphocyte Subsets in Baricitinib-Treated Patients with Rheumatoid Arthritis in A Phase 3 Study (RA-BEAM). Annals of the Rheumatic Diseases. 75. 262–263. 3 indexed citations
8.
Emery, Paul, Iain B. McInnes, M. C. Genovese, et al.. (2016). A7.16 Characterisation of changes in lymphocyte subsets in baricitinib-treated patients with rheumatoid arthritis in two phase 3 studies. Annals of the Rheumatic Diseases. 75. A62–A62. 10 indexed citations
9.
Abraham, Aby, et al.. (2014). Streptococcus pyogenes Sternoclavicular Septic Arthritis in a Healthy Adult. Clinical Medicine & Research. 12(3-4). 155–159. 4 indexed citations
10.
11.
Dyck, Roland, et al.. (1985). The Effect of T-2 Toxin on the Acute Phase Reaction in Mice. Journal of the American College of Toxicology. 4(1). 71–78. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luciano Ibba Breakdown of academic impact, for papers by P. Modiano Breakdown of academic impact, for papers by Domenico Rosace Breakdown of academic impact, for papers by Mariafrancesca Catalano Breakdown of academic impact, for papers by Megan N. Landis Breakdown of academic impact, for papers by Ricardo Madrigal‐Burgaleta Breakdown of academic impact, for papers by Karl M. Hoegler Breakdown of academic impact, for papers by Hye Yoon Jang Breakdown of academic impact, for papers by William C. Ports Breakdown of academic impact, for papers by Teppei Hagino
Rankless by CCL
2026